2008
DOI: 10.1124/dmd.108.021709
|View full text |Cite
|
Sign up to set email alerts
|

Regio- and Stereospecific N-Glucuronidation of Medetomidine: The Differences between UDP Glucuronosyltransferase (UGT) 1A4 and UGT2B10 Account for the Complex Kinetics of Human Liver Microsomes

Abstract: ABSTRACT:Medetomidine is a chiral imidazole derivate whose dextroenantiomer is pharmacologically active.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
52
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 55 publications
(57 citation statements)
references
References 26 publications
5
52
0
Order By: Relevance
“…Although initially considered an orphan enzyme, more recent studies have shown that UGT2B10, like UGT1A4, catalyzes the N-glucuronidation of a number of xenobiotics that incorporate an aliphatic tertiary amine or aromatic N-heterocyclic group (Kaivosaari et al, 2011). Known substrates are nicotine and its oxidation product cotinine (Chen et al, 2007;Kaivosaari et al, 2007); desloratadine (Kazmi et al, 2015a); medetomidine (Kaivosaari et al, 2008); the tricyclic antidepressants (TCAs) amitriptyline, clomipramine, imipramine, and trimipramine (Chen et al, 2007;Zhou et al, 2010;Kato et al, 2013); several tobacco-specific nitrosamines (Chen et al, 2008); RO5263397 (Fowler et al, 2015); and miscellaneous drugs that include diphenhydramine, ketoconazole, ketotifen, midazolam, olanzapine, pizotifen, and tamoxifen (Erickson-Ridout et al, 2011;Kato et al, 2013). Consistent with the known selectivity of UGT1A4 for N-glucuronidation (Kubota et al, 2007), most, if not all, UGT2B10 substrates are additionally glucuronidated by UGT1A4 and biphasic kinetics are frequently observed when human liver microsomes (HLM) are used as the enzyme source (Kaivosaari et al, 2011;Kato et al, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…Although initially considered an orphan enzyme, more recent studies have shown that UGT2B10, like UGT1A4, catalyzes the N-glucuronidation of a number of xenobiotics that incorporate an aliphatic tertiary amine or aromatic N-heterocyclic group (Kaivosaari et al, 2011). Known substrates are nicotine and its oxidation product cotinine (Chen et al, 2007;Kaivosaari et al, 2007); desloratadine (Kazmi et al, 2015a); medetomidine (Kaivosaari et al, 2008); the tricyclic antidepressants (TCAs) amitriptyline, clomipramine, imipramine, and trimipramine (Chen et al, 2007;Zhou et al, 2010;Kato et al, 2013); several tobacco-specific nitrosamines (Chen et al, 2008); RO5263397 (Fowler et al, 2015); and miscellaneous drugs that include diphenhydramine, ketoconazole, ketotifen, midazolam, olanzapine, pizotifen, and tamoxifen (Erickson-Ridout et al, 2011;Kato et al, 2013). Consistent with the known selectivity of UGT1A4 for N-glucuronidation (Kubota et al, 2007), most, if not all, UGT2B10 substrates are additionally glucuronidated by UGT1A4 and biphasic kinetics are frequently observed when human liver microsomes (HLM) are used as the enzyme source (Kaivosaari et al, 2011;Kato et al, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, it has been reported that hepatic UGT1A4 and 2B10 catalyze the N-glucuronidation of aromatic N-heterocycles in humans [18,19]. However, BCP-NG formation by hUGT1A4 was <10 pmol equivalents/min/mg protein (Figure 3).…”
Section: Discussionmentioning
confidence: 99%
“…However, BCP-NG formation by hUGT1A4 was <10 pmol equivalents/min/mg protein (Figure 3). The level of hUGT1A4 mRNA in tissues other than the liver is either very low [18,19] or below the detection limit [25]. Therefore, it seems that the contribution of UGT1A4 to BCP-NG formation is negligible.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations